×
About 31,173 results

ALLMedicine™ Pancreatitis Center

Research & Reviews  9,922 results

Utilization Pattern of Prophylactic Measures for Prevention of Post-ERCP Pancreatitis: ...
https://doi.org/10.1016/j.gie.2023.01.049
Gastrointestinal Endoscopy; Ashat M, Kandula S et. al.

Feb 5th, 2023 - Post ERCP pancreatitis (PEP) is the most frequent adverse event of endoscopic retrograde cholangiopancreatography (ERCP). Various prophylactic measures are endorsed by ASGE (American Society of Gastrointestinal Endoscopy) and ESGE (European Societ...

Does CPT Modifier 22 Appropriately Reflect a Difficult Pancreaticoduodenectomy? A Retro...
https://doi.org/10.1097/XCS.0000000000000609
Journal of the American College of Surgeons; Mustansir F, Jajja MR et. al.

Feb 4th, 2023 - Current Procedural Terminology (CPT) coding allows addition of a two-digit modifier code to denote particularly difficult procedures necessitating additional reimbursement, called the Modifier 22. The use of Modifier 22 in relation to pancreatic s...

Methods of tissue preparation after EUS-guided tissue acquisition without rapid on-site...
https://doi.org/10.1111/jgh.16137
Journal of Gastroenterology and Hepatology; Phan VA, Ruszkiewicz A et. al.

Feb 4th, 2023 - In the absence of rapid on-site evaluation (ROSE), it is not clear which method of tissue preparation is best to process tissue obtained from EUS-guidance. Cytological-smearing (CS), cell-block (CB) and direct-histology (DH) are the available tech...

Proteome-wide Mendelian randomization identifies causal links between blood proteins an...
https://doi.org/10.1053/j.gastro.2023.01.028
Gastroenterology Bourgault J, Abner E et. al.

Feb 4th, 2023 - Acute pancreatitis (AP) is a complex disease and the leading cause of gastro-intestinal disease-related hospital admissions. Few therapeutic options exist for AP prevention. Blood proteins with causal evidence may represent promising drug targets,...

Bacterial Sepsis
http://emedicine.medscape.com/article/234587-overview

Feb 3rd, 2023 - Practice Essentials Definitions Sepsis is a life-threatening syndrome usually caused by bacterial infection. Sepsis is a response of the body's immune system that results in organ dysfunction or failure. The systemic inflammatory response syndrome...

see more →

Guidelines  35 results

American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis pre...
https://doi.org/10.1016/j.gie.2022.10.005
Gastrointestinal Endoscopy; Buxbaum JL, Freeman M et. al.

Dec 15th, 2022 - American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: summary and recommendations.|2022|Buxbaum JL,Freeman M,Amateau SK,Chalhoub JM,Coelho-Prabhu N,|adverse effects,etiology,prevention & control,

American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis pre...
https://doi.org/10.1016/j.gie.2022.09.011
Gastrointestinal Endoscopy; , Buxbaum JL et. al.

Dec 15th, 2022 - American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: methodology and review of evidence.|2022| ,Buxbaum JL,Freeman M,Amateau SK,Chalhoub JM,|adverse effects,methods,etiology,prevention & control,

AGA Clinical Practice Update on the Endoscopic Approach to Recurrent Acute and Chronic ...
https://doi.org/10.1053/j.gastro.2022.07.079
Gastroenterology Strand DS, Law RJ et. al.

Aug 26th, 2022 - The purpose of this American Gastroenterological Association (AGA) Clinical Practice Update Expert Review is to provide practical, evidence-based guidance to clinicians regarding the role of endoscopy for recurrent acute and chronic pancreatitis. ...

Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS; Pro...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019936
Orphanet Journal of Rare Diseases; Mosbah H, Donadille B et. al.

Apr 21st, 2022 - Dunnigan syndrome, or Familial Partial Lipodystrophy type 2 (FPLD2; ORPHA 2348), is a rare autosomal dominant disorder due to pathogenic variants of the LMNA gene. The objective of the French National Diagnosis and Care Protocol (PNDS; Protocole N...

JPN clinical practice guidelines 2021 with easy-to-understand explanations for the mana...
https://doi.org/10.1002/jhbp.1146
Journal of Hepato-biliary-pancreatic Sciences; Takada T, Isaji S et. al.

Apr 8th, 2022 - In preparing the Japanese (JPN) guidelines for the management of acute pancreatitis 2021, the committee focused the issues raised by the results of nationwide epidemiological survey in 2016 in Japan. In addition to a systematic search using the pr...

see more →

Drugs  644 results see all →

Clinicaltrials.gov  836 results

Peritoneal Vacuum Therapy to Reduce Inflammatory Response From Abdominal Sepsis/Injury
https://clinicaltrials.gov/ct2/show/NCT01355094

Feb 3rd, 2023 - Excessive pressure within the peritoneal cavity, known as intra-abdominal hypertension (IAH), can adversely affect not only intra-peritoneal organ function, but also other organ systems throughout the body. When IAH > 20 mmHg induces new organ dys...

RCT on Robotic vs. Endo-laparoscopic Approach for Difficult Choledocholithiasis
https://clinicaltrials.gov/ct2/show/NCT05611840

Feb 2nd, 2023 - Background (i) Background information Gallstone disease is a very common disease identity in developed countries, causing a major health burden. There is an estimate of 20 - 25 million adults diagnosed to have gallstone disease annually, resulting...

Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System
https://clinicaltrials.gov/ct2/show/NCT02041936

Feb 1st, 2023 - The prognosis for pancreatic cancer is dismal, with a five-year survival rate of 4.9%. Current treatment options include surgical resection, chemotherapy and radiation. Only 15% percent of pancreatic cancers are considered resectable at the time o...

Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis
https://clinicaltrials.gov/ct2/show/NCT05252754

Feb 1st, 2023 - Background: In the US alone, almost 700,000 endoscopic retrograde cholangiopancreatographies (ERCPs) are performed each year, and the utilization of ERCP over the last 10 years has increased due to the established therapeutic benefit of the proced...

Intraductal Transanastomotic Stent in Duct-to-duct Biliary Reconstruction in Liver Transplantation
https://clinicaltrials.gov/ct2/show/NCT04804215

Jan 30th, 2023 - Aim of study Primary end-point To compare and evaluate the incidence of biliary tract complications within 6 months after surgery according to the presence or absence of an intrabiliary stent during biliary reconstruction in liver transplantation....

see more →

News  958 results

42-year-old man • altered mental status • vomiting • agitation • Dx?
https://www.mdedge.com/familymedicine/article/260817/pain
MDedge Family Medicine; Faiza Khondoker, DO, Erik Weitz, DO et. al.

Jan 26th, 2023 - THE CASE A 42-year-old man with a history of bipolar disorder with psychotic features, asthma, and chronic pain was brought to the emergency department (ED) by his father due to altered mental status, coughing, and vomiting. The patient was unable.

Duodenoscopes With Disposable Caps Led to Less Microbial Contamination
https://www.medpagetoday.com/gastroenterology/generalgastroenterology/102764

Jan 23rd, 2023 - Use of duodenoscopes with disposable elevator caps during endoscopic retrograde cholangiopancreatography (ERCP) led to lower rates of contamination following high-level disinfection compared with standard scope designs, and did not affect the tech...

Albuminuria Remission With Meds; Tzield's High Cost; Osteoporosis Prevention Lags
https://www.medpagetoday.com/endocrinology/generalendocrinology/101956

Nov 29th, 2022 - "Best" medical treatment with drugs such as SGLT2 inhibitors and GLP-1 receptor agonists was just as effective as Roux-en-Y gastric bypass at achieving albuminuria remission in patients with diabetic kidney disease and class I obesity. (eClinicalM...

FDA Approves Additional Dosing Schedule for Rylaze in ALL and LBL
https://www.onclive.com/view/fda-approves-additional-intramuscular-dosing-schedule-for-rylaze-in-all-and-lbl

Nov 18th, 2022 - The FDA has approved a supplemental biologics license application to add a Monday/Wednesday/Friday (MWF) intramuscular dosing schedule for asparaginase erwinia chrysanthemi (recombinant)-rywn (Rylaze).1 In June 2021, Rylaze was approved for use a...

Ponatinib Provides Higher Rate of MRD-negative CR Vs Imatinib in Newly Diagnosed Ph+ ALL
https://www.onclive.com/view/ponatinib-provides-higher-rate-of-mrd-negative-cr-vs-imatinib-in-newly-diagnosed-ph-all

Nov 17th, 2022 - Ponatinib (Iclusig) plus reduced-intensity chemotherapy produced a higher rate of minimal residual disease (MRD)–negative complete remission compared with imatinib (Gleevec) in patients with newly diagnosed Philadelphia chromosome (Ph)–positive ac...

see more →

Patient Education  74 results see all →